Marimed (MRMD) COO Timothy Shaw Receives 40,625 Shares (RSU Vesting)

What Happened

• Timothy Shaw, Chief Operating Officer of Marimed Inc. (MRMD), had 40,625 restricted stock units (RSUs) convert to common shares on May 29, 2026. The conversion is recorded as a derivative exercise (code M) at $0.00 per share. To satisfy tax withholding (code F), the issuer withheld 14,077 shares at $0.08 per share, totaling $1,133. That leaves a net issuance of 26,548 shares to Shaw from this vesting event.

Key Details

• Transaction date: May 29, 2026 (filed June 2, 2026). Filing does not indicate a late filing code in the provided excerpt.
• Vesting/Conversion: 40,625 RSUs converted to common stock (code M) at $0.00 per share.
• Tax withholding: 14,077 shares withheld (code F) at $0.08 per share for $1,133.
• Net shares received by insider: 26,548 shares (40,625 − 14,077).
• Shares owned after transaction: Not specified in the provided lines of this filing.
• Relevant footnotes: F1 (RSUs convert 1:1), F2 (shares withheld to satisfy taxes), F4 (original RSU grant dated Nov 29, 2024 with remaining tranches vesting on Nov 29, 2026; May 29, 2027; Nov 29, 2027). F3 notes certain shares are held in an irrevocable trust for the benefit of the reporting person’s children and the reporting person disclaims beneficial ownership of those trust shares.

Context

• This was not an open-market purchase or sale but a standard RSU vesting with cashless tax withholding (company retained shares instead of cash). Such transactions are routine compensation events and do not by themselves indicate a buy/sell signal. The filing shows conversion of derivatives (RSUs) and automatic withholding to cover tax obligations.